Nikolai Kley - Concepedia

Author

Nikolai Kley

Bristol-Myers Squibb (United States)

Also Known As

N Kley, N. A. Kley, N. KLEY, N. Kley, Nikolai A. Kley, Nikolai Kley, Nikolai kley

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Max Planck Institute of Psychiatry Harvard University Bristol-Myers Squibb (Germany)Massachusetts General Hospital

About

Nikolai Kley is an author at Bristol-Myers Squibb (United States) specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	29	3.8K
2	Natural Sciences	9	9	565
3	Health Sciences	2	2	901
4	Social Sciences	2	2	94
5	Engineering	1	1	193

Nikolai Kley

Publications

Citations

H-Index

Page 1

	Year	Citations
Induction of the growth inhibitor IGF-binding protein 3 by p53 Leonard Buckbinder, Randy Talbott, Susana Velasco-Miguel, Nature Cell ProliferationCell BiologyCell GrowthMedicineRadiation Oncology	1995	877
The von Hippel-Lindau Tumor Suppressor Protein Is Required for Proper Assembly of an Extracellular Fibronectin Matrix Michael Ohh, Robert L. Yauch, Kim M. Lonergan, Molecular Cell FibrosisMedicineProper AssemblyPathologyCell-matrix Interaction	1998	478
High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. A. Bianchi, Shin‐ichiro Mitsunaga, J Q Cheng, Proceedings of the National Academy of Sciences Primary Malignant MesotheliomasMalignant MesotheliomasTumoral PathologyGliomaMm Cell Lines	1995	363
PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes Susana Velasco-Miguel, Leonard Buckbinder, Patrice Jean, Oncogene Gadd FamilyTumor BiologyDna DamageMedicineTumor Suppressor	1999	253
Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types A. Bianchi, Tetsuo Hara, Vijaya Ramesh, Nature Genetics Neuro-oncologySomatic VariantTumor HeterogeneityTranscript IsoformsPathology	1994	232
Regulation of the Sequence-specific DNA Binding Function of p53 by Protein Kinase C and Protein Phosphatases Ivone M. Takenaka, Francine Morin, Bernd R. Seizinger, Journal of Biological Chemistry	1995	197
Exon scanning for mutation of the <i>NF2</i> gene in schwannomas Lee B. Jacoby, Mia MacCollin, David N. Louls, Human Molecular Genetics Neuro-oncologyEngineeringSomatic VariantNf2 ExonsGenetic Disorder	1994	193
p53 Regulates Insulin-Like Growth Factor-I (IGF-I) Receptor Expression and IGF-I-Induced Tyrosine Phosphorylation in an Osteosarcoma Cell Line: Interaction between p53 and Sp1 Claes Ohlsson, Nikolai Kley, Haim Werner, Endocrinology Cancer ResearchOncogenic AgentMedicineReceptor Tyrosine KinaseInsulin-like Growth Factor-i	1998	152
Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Ronald H. Lekanne Deprez, A B Bianchi, N A Groen, PubMed	1994	149
Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity Catherine Blankenship, Joseph G. Naglich, Jean M. Whaley, Oncogene Initiation CodonAlternate ChoiceOncogenic AgentGeneticsTranscription Regulation	1999	140

Page 1